Lates News

Pre-market trading in US pharmaceutical stocks saw a general decline, with Novo Nordisk (NVO.N) down 5.25%, AbbVie (ABBV.N) down 4.12%, AstraZeneca (AZN.O) down 3.8%, Novartis (NVS.N) down 3.7%, and Gilead Sciences (GILD.O) down 3.46%. Trump announced plans to sign an executive order to immediately lower drug prices by 30%-80%.